GDGustavo H. Dayan

Gustavo H. Dayan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gustavo H. Dayan has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico

    by Gustavo H. Dayan, Margaret Thorley, Yasuhiro Yamamura, Nayra Rodríguez, Steve McLaughlin, Lourdes M. Torres, Antonio Seda, Marcia Carbia, Lorraine N. Alexander, Victor Caceres, et al.

    BackgroundThe World Health Organization (WHO) recommends the discontinuation of oral poliovirus vaccine after eradication of wild poliovirus. Studies


  • Open Access

    Efforts at Rubella Elimination in the United States: The Impact of Hemispheric Rubella Control

    by Gustavo H. Dayan, Carlos Castillo-Solórzano, Margarita Nava, Bradley S. Hersh, Jon Andrus, Romeo Rodríguez, Susan E. Reef

    We examined rubella vaccination trends, rubella surveillance, and disease patterns for the Americas, Mexico, and the United States, to evaluate the impact of hemispheric rubella control on rubella elimination in the United States during 1997–2004. In 1997, 130,375 rubella cases were reported in the Americas, with 38,042 reported in Mexico. Over the next 7 years, a rubella control initiative resulted in the administration of ∼110 million rubella-containing vaccine doses in Latin America, with 77.7 million doses administered within Mexico. By 2004, the number of reported rubella cases had declined to 3103 in the Americas and 698 in Mexico. Concurrently, the number of rubella cases in the United States fell from 817 during 1997–1999 to <25 cases/year from 2001 onward, with loss of seasonality and geographic clustering, despite no change in vaccination rates. Implementation of rubella control strategies in the Americas, particularly in Mexico, appears to have facilitated rubella elimination in the United States.


  • Open Access

    Assessment of Delay in Age-appropriate Vaccination Using Survival Analysis

    by Gustavo H. Dayan, Kate M. Shaw, Andrew L. Baughman, Liliana C. Orellana, Raúl Forlenza, Alejandro Ellis, Jorge Chaui, Silvia Kaplan, Peter Strebel

    Assessment of delay in age-appropriate vaccination provides more information about timeliness of vaccination than up-to-date vaccination coverage. The authors applied survival analysis methods to data from a vaccination coverage survey among children aged 13–59 months conducted in Argentina in 2002. By age 19 months, 43% of children (95% confidence interval (CI): 40, 46) were vaccinated with the fourth dose of diphtheria, tetanus, and pertussis (DTP4). By age 13 months, 55% of children (95% CI: 52, 57) were vaccinated with measles-containing vaccine. By age 7 months, 33% of children (95% CI: 27, 40) were vaccinated with the third dose of hepatitis B. Compared with firstborn children, third children were more likely to be delayed for DTP4 (relative risk (RR) = 1.41, 95% CI: 1.22, 1.62), measles-containing vaccine (RR = 1.54, 95% CI: 1.32, 1.78), and the third dose of hepatitis B (RR = 1.31, 95% CI: 1.03, 1.67). Children whose caregivers had completed secondary school were less likely to be delayed for DTP4 (RR = 0.68, 95% CI: 0.52, 0.90) compared with those whose caregivers had not completed primary school. Survival analysis methods were helpful in measuring vaccine uptake and should be considered in future surveys when assessing delay in age-appropriate vaccination.


  • The Cost of Containing One Case of Measles: The Economic Impact on the Public Health Infrastructure—Iowa, 2004

    by Gustavo H. Dayan, Ismael R. Ortega-Sánchez, Charles W. LeBaron, M. Patricia Quinlisk, the Iowa Measles Response Team

    Background. In February 2004, students from a college in Iowa, with a high proportion of nonmedical exemptions to vaccination, traveled to India; one fourth of the students contracted measles while there. One exposed, susceptible student returned home during his infectious period, necessitating 2 months of containment efforts in Iowa. Objective. The objective of this study was to measure the direct costs of measles containment from a public health system perspective. Methods. We evaluated activities performed, personnel time/materials allocated, and direct costs incurred in 2004 US dollars by the Iowa public health infrastructure. The study period was defined as March 5, 2004 (when the Iowa Department of Public Health was first contacted about the case), through May 12, 2004 (when a final meeting was held on the containment effort). Results. A total of 2525 hours of personnel time were expended to review flight manifests, contact exposed passengers, set up vaccination clinics, trace >1000 potentially exposed contacts, and institute and enforce quarantine orders for vaccination refusers. Two thousand twenty-five phone calls were received from the public, and 2243 miles were driven by staff. The temporal distribution of personnel time was characterized by marked peaks at the report of potential secondary cases. The total estimated cost was $ 142452. Conclusions. The direct cost to the public health infrastructure of containing 1 case of measles was far greater than the estimated cost of uncomplicated individual illness (less than $100). Economic analyses of vaccine-preventable diseases may need to go beyond the costs of individual illness to account for the costs of protecting society.


  • Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002

    by G. H. Dayan, M. S. Panero, A. Urquiza, M. Molina, S. Prieto, M. DEL Carmen Perego, G. Scagliotti, D. Galimberti, G. Carroli, C. Wolff, et al.

    To assess rubella and measles susceptibility among women of childbearing age we conducted a cross-sectional seroprevalence study in four cities and one rural area in Argentina. A convenience sample of women aged 15–49 years seeking care in public health-care institutions was selected (n=2804). Serum specimens were tested for rubella and measles IgG antibody titres. The overall susceptibility to rubella and measles was 8·8 and 12·5% respectively. Seroprevalence differences were found for both rubella (PP=0·002) across sites. Rubella seroprevalence was higher in women aged [ges ]40 years than in younger women (P=0·04). Measles seroprevalence tended to increase with age (PPP<0·001) were factors associated with measles seronegativity. Our findings support the introduction of supplemental immunization activities targeting adolescents and young adults to prevent congenital rubella syndrome and measles outbreaks over time.


  • Tracking vaccine lot lifecycles using reports to the Vaccine Adverse Event Reporting System (VAERS)

    by Gustavo H. Dayan, John Iskander, John Glasser, Roseanne English-Bullard, Kathleen E. Fullerton, Robert Chen


  • Open Access

    Varicella Seroprevalence and Molecular Epidemiology of Varicella-Zoster Virus in Argentina, 2002

    by Gustavo H. Dayan, María S. Panero, Roberto Debbag, Ana Urquiza, Marta Molina, Susana Prieto, María del Carmen Perego, Graciela Scagliotti, Diana Galimberti, Guillermo Carroli, et al.

    There is limited data on immunity against varicella-zoster virus (VZV) in adults in different parts of Argentina, and it is not known which VZV strains are circulating in Argentina. The objectives of this study were as follows: (i) to evaluate seroprevalence of varicella among adults, assessing the accuracy of clinical history and determining the sociodemographic factors associated with seropositivity; and (ii) to determine the VZV strains circulating in Argentina. A cross-sectional serological survey enrolling 2,807 women aged 15 to 49 years attending public health-care settings in four cities in Argentina (i.e., Buenos Aires, Salta, Mendoza, and Rosario) and one rural area was conducted from August to November 2002. Specimens for identification of VZV strains were obtained from vesicular lesions from 13 pediatric patients with varicella from different areas of the country. PCR amplification was used for genotyping. The overall seroprevalence of varicella antibodies was 98.5% (95% confidence interval, 98.0 to 98.9), ranging from 97.2% in central Buenos Aires to 99.3% in southern Buenos Aires and Salta. Varicella seroprevalence increased with age. Crowding and length of residence in the same place were associated with seropositivity. The positive predictive value of varicella history for immunity to varicella was 99.4%; however, the negative predictive value was 2.5%. The European genotype was identified in all viral specimens. In Argentina, seroprevalence in women more than 15 years old was high regardless of the area of residence. Negative or uncertain varicella history was not a good predictor of immunity. VZV genotype was stable in all areas of the country.


  • Open Access

    Assessment of areas at increased risk for poliovirus circulation in Ecuador.

    by Gustavo H. Dayan, Rodrigo Rodríguez, Jan Vinjé, Nancy Vásconez, Víctor Cáceres, Nicole Gregoricus, Mark Sobsey, Mauricio Landaverde

    To assess areas at risk for poliovirus circulation in Ecuador, we first selected provinces at highest risk based on low immunization coverage with three doses of oral poliovirus vaccine, and a low number of reported cases of acute flaccid paralysis (AFP). Subsequently, we reviewed discharge data for the period 1996--2000 for diagnoses compatible with AFP in the only two national referral hospitals in Quito, and at least two main hospitals in each of the six selected provinces. Environmental samples from one or two cities/towns in each selected province were tested for poliovirus. Of the 14 identified AFP-compatible cases, 8 (57%) had been previously reported and investigated. We visited four out of the six unreported cases; none of those four had sequelae compatible with poliomyelitis. From the 14 environmental samples taken, we identified Sabin viruses in six of the samples; no vaccine-derived polioviruses were isolated. Using this methodology, we found no evidence of undetected poliovirus circulation in Ecuador.


  • Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002

    by Gustavo H. Dayan, Liliana C. Orellana, Raúl Forlenza, Alejandro Ellis, Jorge Chaui, Silvia Kaplan, Peter Strebel

    To estimate antigen-specific and series-complete vaccination coverage among children aged 13 to 59 months in Buenos Aires; to compare the results of a community-based household survey with coverage rates obtained from administrative records; and to identify risk factors for incomplete vaccination. Census tracts in Buenos Aires were surveyed systematically in March and April, 2002. Three children aged 13 to 24 months and 25 to 59 months were surveyed per block in each census tract. Written documentation of vaccination was required. Risk factors associated with incomplete vaccination were identified with univariate analysis and multivariate logistic regression. A total of 1391 children were surveyed. Antigen-specific coverage ranged from 69.4% (95% CI 66.7%-72%) for Haemophilus influenzae type b vaccination to 99% (95% CI 98.4%-99.6%) for BCG vaccination. Except for measles, coverage estimates found in the survey did not differ substantially from those obtained from city health authority records. Multivariate logistic regression analysis showed child's age (P < 0.001) and vaccination provider (public or private) (P = 0.001) to be risk factors associated with incomplete vaccination. Not being the first child (P < 0.001) was associated with incomplete coverage under the long-standing program. Living in the Northern zone of the city (P = 0.001), being uninsured (P = 0.02), and lower educational level of the primary caregiver (P = 0.04) were risk factors associated with incomplete coverage under the current vaccination program. Although coverage rates for some vaccines were high, complete vaccination coverage remains low among children aged 13 to 59 months in Buenos Aires. Increasing coverage will require better access to vaccination, particularly in sections of the community with risk factors.


  • Cost-effectiveness of three different vaccination strategies against measles in Zambian children

    by Gustavo H Dayan, Lisa Cairns, Nalinee Sangrujee, Anne Mtonga, Van Nguyen, Peter Strebel